Current Drug Therapy - Current Issue

In patients with PCOS, oxidative stress is caused by an imbalance between antioxidants and reactive oxygen species, which increases the risk of cardiovascular disease. Existing therapies, which mostly include synthetic medications, often result in serious adverse effects. Alternatively, a secure and efficient method of treating PCOS appears to be the mix of phytoconstituents and lifestyle changes.

This review examines the global impact of PCOS, a prevalent hormonal disorder combining genetic, environmental, behavioral, and endocrine factors, and the potential side effects of synthetic medications used for its treatment. The authors conducted a narrative review using major databases like PubMed, ScienceDirect, and Google Scholar from October 1^st to November 25^th, 2023. They analyzed data from review articles, research articles, and meta-analyses published until August 2023 on pathogenesis, diagnosis, management, synthetic and herbal treatment, and nanotechnology effective in PCOS treatment, including those related to the theme.

PCOS affects women globally, and synthetic agents like insulin sensitizers, contraceptive pills, and anti-androgens may have numerous long-term health effects. A natural substitute for contemporary pharmaceuticals, herbal therapies are prized for their health benefits. Scientific studies support the safety and effectiveness of herbal bio-actives, which utilize diverse phytochemicals to reduce PCOS symptoms.

To overcome the side effects of the synthetic agents, more influence is given to the natural way of curbing the syndrome for a healthier life. Thus, this review combines the potential advantages of utilizing various herbal plants for PCOS treatment by amalgamating findings from numerous literature studies.

Polymeric micelle-based drug delivery systems have emerged as a beacon of hope in the challenging landscape of breast cancer therapy. This review aimed to explore the recent advancements and promising developments in the field, offering an in-depth analysis of their potential and challenges. The significance of this study lies in providing a comprehensive examination of the current advances in polymeric micelles technology, which have the potential to improve the efficiency and specificity of breast cancer therapy while minimizing adverse events.

Polymeric micelles offer a revolutionary therapy by encapsulating therapeutic agents, allowing for controlled drug release and the precise targeting of malignant cells, while lowering systemic toxicity. Recent advances have focused on enhancing targeting strategies, including active and passive targeting, to increase the specificity of polymeric micelle-based therapies. A systematic review of literature was carried out using databases, like PubMed, Scopus, and Web of Science, which included papers published between 2010 and 2023. The selection criteria of the literature focused on the drug-loading capabilities and targeting strategies of the polymeric micelles, which could be advantageous for breast cancer treatment.

Clinical drug approaches leverage the versatility of micelles to co-deliver multiple agents, addressing the multifaceted nature of breast tumors and combating drug resistance. Additionally, polymeric micelles are finding applications in breast cancer diagnostics and imaging, enabling early detection and precise monitoring. The journey of polymeric micelle-based breast cancer therapy extends to formulation and engineering, preclinical and clinical studies, and confronts regulatory and commercialization challenges. However, the horizon is illuminated by emerging technologies, like personalized medicine, biomarker-driven targeting, and integration with novel therapies, promising a future where breast cancer treatment is tailored to individual patients and marked by improved efficacy and reduced side effects.

In conclusion, this review underscores the transformative potential of polymeric micelle-based delivery systems in breast cancer therapy.

Prodrugs represent a strategically designed category of medicinal compounds aimed at optimizing drug pharmacokinetics. By modifying the pharmacological action of the drug within a prodrug, subsequent enzymatic bioconversion in the human body facilitates the release of the active drug. This strategy has been highly effective, as demonstrated by the substantial number of prodrugs found in commercial pharmaceutical products. Prodrugs have emerged as a recognized strategy for augmenting the physical, chemical, biological, or pharmacokinetic attributes of pharmacologically active molecules in the realm of drug research and development.

This systematic review intended to offer insights into the recent developments in the prodrug approach used in drug research and development, with a focus on highlighting its effectiveness. The objective was to illustrate the diverse applications of prodrugs and their impact on enhancing drug properties and therapeutic outcomes.

This review is centered on the most recent developments in the prodrug approach used for drug development and research. The prodrug concept has a wide range of practical uses, some of which are illustrated in this review article. These illustrations are categorized based on the intention behind their creation.

Prodrugs have been designed to address challenges, such as poor water solubility and low bioavailability. Strategies, like using neutral or charged promoieties, have been reported to be successful in enhancing solubility. For permeability and bioavailability, prodrugs have been employed to mask polar groups, enabling better absorption. Prolonged half-life prodrugs have been developed to extend drug action, while tissue-targeted delivery prodrugs have shown promise in enhancing drug delivery to specific sites.

Prodrug design offers promising strategies to optimize drug delivery and efficacy. Despite challenges, ongoing clinical trials and research efforts indicate the potential of prodrugs in improving therapeutic outcomes. Addressing formulation challenges and understanding pharmacokinetic variability are essential for successful prodrug development.

Stroke is a medical disorder defined by focal neurological deficits caused by vascular impairment (hemorrhage or infarction) in the CNS (Central Nervous System). Currently the second biggest cause of morbidity worldwide, strokes continue to be a deadly disease.

This review aimed to elucidate the stroke’s pathophysiology, both changeable and unchangeable risk factors associated with stroke, including prevention of stroke, its diagnosis, as well as treatment.

The articles were collected involving the research on stroke with the help of different sources, like PubMed, Science Direct, and Google. Many manuscripts were collected and analyzed, and the relevant ones were considered for the present manuscript.

A brain CT scan has been found to be the first step in the management of Cerebrovascular Accident (CVA) in order to distinguish between ischemic and hemorrhagic stroke types. Beyond stroke classification, imaging has been observed to serve as a powerful tool for ruling out alternative diagnoses, predicting stroke outcomes, and facilitating appropriate treatment planning.

Stroke is the second foremost cause of death as well as disability worldwide, leading to substantial economic losses. Therefore, better treatment and improved management after stroke are a global health priority. Modifying risk factors can decrease the chances of occurrence of stroke. Also, correct diagnosis should be done to diagnose the presence of stroke and its type. Proper treatment should be provided, like perfusion, glucose management, antiplatelet therapy, antihypertensive therapy, stem cell therapy, neural response and rehabilitation, increased awareness, lifestyle changes, stress management, etc. Exercise can also help positively to reduce the chances of stroke.

Paraquat (PQ) is one of the most common herbicides used in agriculture that can lead to very acute toxicity in mammals. It has been reported that PQ has destructive effects on the lungs.

We aimed to investigate the effect of N-acetyl Cysteine (NAC) and Vitamin D (Vit D) on the oxidative toxicity of the lung in subacute paraquat exposure. 36 male albino Wistar rats at 8 weeks were randomly divided into 6 groups (n=6). A control group, a PQ-intoxicated group (5 mg/kg body weight), a Vit D-treated group (2 μg/kg), an NAC-treated group, a PQ (6.25 mg/kg) + Vit D group, and finally a PQ + NAC group, each was treated for 7 days.

In this experimental study, Lipid Peroxidation (LPO), Total Oxidant Status (TOS), Total Antioxidant Capacity (TAC), Total Thiol Groups (TTG), and Hydroxyproline (Hyp) levels in lung tissue were evaluated.

PQ exposure resulted in a substantial elevation of LPO, TOS, and Hyp levels. Conversely, TAC and TTG content demonstrably declined. Administration of either PQ+Vit D or PQ+NAC significantly reduced LPO, TOS, and Hyp levels in the PQ-exposed rats compared to the PQ group alone. Conversely, TAC and TTG content significantly increased in these groups. These findings suggest that both vitamin D and NAC may function as free radical scavengers and potential antioxidant agents, potentially alleviating the detrimental effects of PQ poisoning on the lungs.

The present study has demonstrated the administration of Vit D and NAC to significantly mitigate PQ-induced lung injury in rats. This protective effect can be likely attributed to their modulation of the oxidant/antioxidant balance, as evidenced by reductions in LPO, TOS, and Hyp levels, alongside increases in TAC and TTG content. These findings suggest that vitamin D and NAC may function as free radical scavengers and antioxidant enhancers, offering protection against PQ-induced oxidative stress and subsequent lung tissue damage.